Previous studies have shown that TGF-β1 is a key cytokine in fibrosis [43] and that inhibitors targeting TGF-β1 signaling and its receptors can reduce bleomycin-induced pulmonary fibrosis in mice [44]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.